EUVIMEDEUVIMED entdecken
Vergleichsstudie

Sex Disparities in Atrial Fibrillation and Atrial Flutter Presentation, Treatment, and Outcomes in Reproductive‐Aged Individuals

Lara C Kovell, Jenna Barnes, Cailey Denoncourt, Ziyue Wang, Soroosh Kiani, Gianna Wilkie iD

Journal of Cardiovascular Electrophysiology · 2026-11 · 37 (11) · 2439-2451

DOI: 10.1111/jce.70412 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 08.07.2026. Verfasst von Lara C Kovell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, UMass Chan Medical School, Division of Cardiovascular Medicine, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Flutter, Healthcare Disparities, Anti-Arrhythmia Agents. Die Arbeit nennt 22 Literaturangaben. Gefördert von: American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial fibrillation/flutter (AF/AFL) are increasingly seen in reproductive‐aged adults, yet AF/AFL guidelines are largely based on older populations. Sex differences in this age group remain poorly defined. In this study, we examined sex‐based disparities in the presentation, management, and outcomes among reproductive‐aged adults with AF/AFL.

Methods

Using the Get With The Guidelines–Atrial Fibrillation national registry, we included adults (18–50 years) with AF/AFL who were prospectively enrolled from May 2013 to March 2024. The primary exposure was sex and primary outcomes included anticoagulant prescription and rhythm control strategies (cardioversion, AF ablation, or antiarrhythmic therapy). Multivariable logistic regression estimated associations between sex and outcomes, adjusting for covariates including age, race and ethnicity, insurance, and anemia.

Results

Among 14 301 patients with mean age 42.3 ± 7.3 years, women were more symptomatic and had more paroxysmal AF (57.7% vs. 49.9%, p < 0.001), while men had more persistent AF (19.9% vs. 11.6%, p < 0.001). CHA 2 DS 2 VASc scores were significantly higher in women (2.3 ± 1.2 vs. 1.4 ± 1.2 in men, p < 0.001). Despite similar use of antiarrhythmic drugs and anticoagulation, women were 9%–15% less likely to receive rhythm‐control therapies overall (adjusted OR 0.91, 95% CI 0.83–0.99), driven by differences in AF ablation and cardioversion. For both sexes, the proportion of patients undergoing ablation increased while those undergoing cardioversion decreased significantly over time (all p < 0.001). Women undergoing AF ablation experienced more complications (3.7% vs. 1.9%, p = 0.01) and were more likely to have relative or absolute contraindications to anticoagulation (9.0% vs. 7.2%, p < 0.001).

Conclusions

In a large US registry, reproductive‐aged women with AF/AFL were less likely to receive rhythm‐control interventions, experienced more ablation complications, and had more anticoagulation contraindications. These findings highlight persistent sex‐based disparities in the management and outcomes of young adults with AF/AFL, underscoring the need for targeted, sex‐specific approaches to improve treatment inequities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAtrial FlutterHealthcare DisparitiesAnti-Arrhythmia AgentsAnticoagulantsCatheter AblationElectric CountershockHealth Status DisparitiesHumansFemaleMaleTreatment OutcomeRegistriesAdultMiddle AgedSex FactorsRisk FactorsYoung AdultAdolescentRisk AssessmentUnited StatesTime FactorsAge FactorsTreatment Effect HeterogeneityProspective Studies

Stichwörter der Autor:innen

anticoagulationatrial fibrillationatrial flutterrhythm controlsex differencesyoung adults

Substanzen

Anti-Arrhythmia AgentsAnticoagulants

Autor:innen und Institutionen

  • Department of Internal Medicine, UMass Chan Medical School, Division of Cardiovascular Medicine, Worcester, Massachusetts, USA.
  • Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts, USA.
  • Department of Obstetrics and Gynecology, UMass Chan Medical School, Division of Maternal Fetal Medicine, Worcester, Massachusetts, USA.

ORCID-Profile: Gianna Wilkie

Förderung

  • American Heart Association

Zitieren

APA

Kovell, L. C., Barnes, J., Denoncourt, C., Wang, Z., Kiani, S., & Wilkie, G. (2026). Sex Disparities in Atrial Fibrillation and Atrial Flutter Presentation, Treatment, and Outcomes in Reproductive‐Aged Individuals. Journal of Cardiovascular Electrophysiology, 37(11), 2439-2451. https://doi.org/10.1111/jce.70412

Vancouver

Kovell LC, Barnes J, Denoncourt C, Wang Z, Kiani S, Wilkie G. Sex Disparities in Atrial Fibrillation and Atrial Flutter Presentation, Treatment, and Outcomes in Reproductive‐Aged Individuals. Journal of Cardiovascular Electrophysiology. 2026;37(11):2439-2451. doi:10.1111/jce.70412

BibTeX
@article{Kovell2026,
  author = {Kovell, Lara C and Barnes, Jenna and Denoncourt, Cailey and Wang, Ziyue and Kiani, Soroosh and Wilkie, Gianna},
  title = {Sex Disparities in Atrial Fibrillation and Atrial Flutter Presentation, Treatment, and Outcomes in Reproductive‐Aged Individuals},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  volume = {37},
  number = {11},
  pages = {2439--2451},
  doi = {10.1111/jce.70412}
}
Kostenlos starten →